Sunday, 22 September 2019 02:03 GMT
img

Targovax to Present at NeoAg Summit 2018




(MENAFN - PR Newswire)

OSLO, Nov. 16, 2018 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces that CMO Magnus Jäderberg will present at the NeoAg Summit 2018 (formerly Neoantigen Summit) in Boston

NeoAg Summit 2018Date: 16 November 2018 Presenter: Dr. Magnus Jäderberg, CMOPresentation time: 11:00 ETVenue: Hyatt Regency Cambridge, Boston.

Title: TG01, a neo-antigen specific vaccine targeting RAS mutations in solid tumours

Presentation slides will be available on www.targovax.com/Investors .

For further information, please contact:Renate Birkeli, Investor RelationsPhone: +47-922-61-624Email: Media and IR enquires:Andreas Tinglum - Corporate Communications (Norway)Phone: +47-9300-1773Email: Simon Conway/Stephanie Cuthbert - FTI Consulting (International)Phone: +44-20-3727-1000Email:

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/targovax/r/targovax-to-present-at-neoag-summit-2018,c2673975

SOURCE Targovax

Also from this source Nov 01, 2018, 05:45 ET Targovax ASA: Third quarter 2018 Results... Oct 26, 2018, 04:14 ET Targovax ASA: Announcement of Third Quarter 2018 Financial Results... Explore More news releases in similar topics

  • All Summer Health & Safety News Releases
  • All Health
  • Health
  • General Business

MENAFN1611201800701241ID1097704414


Targovax to Present at NeoAg Summit 2018

  Most popular stories  

Day | Week | Month